Modulation of bladder function by luminal adenosine turnover and A1 receptor activation

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 2, 2012, Pages

  Sandeep Prakasam, H ^a   Herrington, Heather ^a   Roppolo, James R ^a   Jackson, Edwin K ^a   Apodaca, Gerard ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclophosphamide induced cystitis; Voiding

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE KINASE; CYCLOPHOSPHAMIDE; ECTO ADENOSINE DEAMINASE; NUCLEOSIDE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER FUNCTION; BLADDER IRRITATION; BLADDER MUCOSA; CONTROLLED STUDY; CYSTITIS; CYSTOMETRY; EXTRACELLULAR MATRIX; FEMALE; MICTURITION; NONHUMAN; OVERACTIVE BLADDER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; RABBIT; RAT; SEROSA; UROTHELIUM;

EID: 84863936052     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00566.2011     Document Type: Article

References (58)

1. Anvari F, Sharma AK, Fernandez LG, Hranjec T, Ravid K, Kron IL, Laubach VE. Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 140: 871-877, 2010.
2. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 5: 117-128, 2004.
3. Apodaca G, Balestreire E, Birder LA. The uroepithelial-associated sensory web. Kidney Int 72: 1057-1064, 2007.
4. Aronsson P, Andersson M, Ericsson T, Giglio D. Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder. Basic Clin Pharmacol Toxicol 107: 603-613, 2010.
5. Balestreire EM, Apodaca G. Apical epidermal growth factor receptor signaling: regulation of stretch-dependent exocytosis in bladder umbrella cells. Mol Biol Cell 18: 1312-1323, 2007.
6. Birder LA. Urothelial signaling. Hand Exp Pharmacol 202: 207-231, 2011.
7. Birder LA, De Groat WC, Apodaca G. Physiology of the urothelium. In: Textbook of the Neurogenic Bladder, edited by Corcos J and Schick E. London; New York: Martin Dunitz, 2008, p. 19-39.
8. Caruso M, Holgate ST, Polosa R. Adenosine signaling in airways. Curr Opin Pharmacol 6: 251-256, 2006.
9. Cohen MV, Downey JM. Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol 103: 203-215, 2008.
10. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148: 2201-2206, 1992.
11. Dang K, Lamb K, Cohen M, Bielefeldt K, Gebhart GF. Cyclophosphamide-induced bladder inflammation sensitizes and enhances P2X receptor function in rat bladder sensory neurons. J Neurol 99: 49-59, 2008.
12. De Groat WC. The urothelium in overactive bladder: passive bystander or active participant? Urology 64: 7-11, 2004.
13. Deussen A. Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch Pharmacol 362: 351-363, 2000.
14. Dhalla AK, Dodam JR, Jones AW, Rubin LJ. Characterization of an NBTI-sensitive equilibrative nucleoside transporter in vascular smooth muscle. J Mol Cell Cardiol 33: 1143-1152, 2001.
15. Drake MJ, Turner WH. Physiology of the smooth muscles of the bladder and urethra. In: Textbook of the Neurogenic Bladder: Adults and Children. London; New York: Martin Dunitz, 2004, p. xviii, 779.
16. Estrela AB, Abraham WR. Adenosine in the inflamed gut: a janus faced compound. Curr Med Chem 18: 2791-2815, 2011.
17. Fields RD, Burnstock G. Purinergic signaling in neuron-glia interactions. Nat Rev Neurosci 7: 423-436, 2006.
18. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharm Rev 53: 527-552, 2001.
19. Gorlach A. Control of adenosine transport by hypoxia. Circ Res 97: 1-3, 2005.
20. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7: 759-770, 2008.
21. Hayashi Y, Takimoto K, Chancellor MB, Erickson KA, Erickson VL, Kirimoto T, Nakano K, de Groat WC, Yoshimura N. Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 α-subunit in rats with cystitis. Am J Physiol Regul Integr Comp Physiol 296: R1661-R1670, 2009.
22. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 92: 4666-4670, 1995.
23. Hirsh AJ, Stonebraker JR, van Heusden CA, Lazarowski ER, Boucher RC, Picher M. Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseases. Biochemistry 46: 10373-10383, 2007.
24. Hofer S, Ivarsson L, Stoitzner P, Auffinger M, Rainer C, Romani N, Heufler C. Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J Invest Dermatol 121: 300-307, 2003.
25. Jackson EK, Ren J, Cheng D, Mi Z. Extracellular cAMP-adenosine pathways in the mouse kidney. Am J Physiol Renal Physiol 301: F565-F573, 2011.
26. Jackson EK, Ren J, Mi Z. Extracellular 2=,3=-cAMP is a source of adenosine. J Biol Chem 284: 33097-33106, 2009.
27. Janig W, Morrison JF. Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res 67: 87-114, 1986.
28. 1 receptor mediates late preconditioning via activation of PKC-signaling pathway. Am J Physiol Heart Circ Physiol 283: H296-H301, 2002.
29. Lanteri-Minet M, Bon K, de Pommery J, Michiels JF, Menetrey D. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 105: 220-232, 1995.
30. Law WR, Conlon BA, Ross JD. The extracellular cardiac purine metabolome in sepsis. Shock 28: 259-264, 2007.
31. Liang BT. Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection. Biochem J 336: 337-343, 1998.
32. Lloyd HG, Fredholm BB. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem Int 26: 387-395, 1995.
33. Loffler M, Morote-Garcia JC, Eltzschig SA, Coe IR, Eltzschig HK. Physiological roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol 27: 1004-1013, 2007.
34. 6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 337: 687-689, 1988.
35. Maggi CA, Conte B, Furio M, Santicioli P, Giuliani S, Meli A. Further studies on mechanisms regulating the voiding cycle of the rat urinary bladder. Gen Pharm 20: 833-838, 1989.
36. Matherne GP, Linden J, Byford AM, Gauthier NS, Headrick JP. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci USA 94: 6541-6546, 1997.
37. McCloskey KD. Interstitial cells in the urinary bladder-localization and function. Neurourol Urodyn 29: 82-87, 2010.
38. Mubagwa K, Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52: 25-39, 2001.
39. Naydenova Z, Rose JB, Coe IR. Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line. Am J Physiol Heart Circ Physiol 294: H2687-H2692, 2008.
40. Negrete HO, Lavelle JP, Berg J, Lewis SA, Zeidel ML. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol Renal Fluid Electrolyte Physiol 271: F886-F894, 1996.
41. Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 15: 19-25, 1994.
42. Phillis JW, Smith-Barbour M. The adenosine kinase inhibitor, 5-iodotubercidin, is not protective against cerebral ischemic injury in the gerbil. Life Sci 53: 497-502, 1993.
43. Picher M, Burch LH, Boucher RC. Metabolism of P2 receptor agonists in human airways: implications for mucociliary clearance and cystic fibrosis. J Biol Chem 279: 20234-20241, 2004.
44. Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC. Ecto 5=-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278: 13468-13479, 2003.
45. Pinna C, Eberini I, Puglisi L, Burnstock G. Presence of constitutive endothelial nitric oxide synthase immunoreactivity in urothelial cells of hamster proximal urethra. Eur J Pharmacol 367: 85-89, 1999.
46. Rieg T, Vallon V. ATP and adenosine in the local regulation of water transport and homeostasis by the kidney. Am J Physiol Regul Integr Comp Physiol 296: R419-R427, 2009.
47. Schaddelee MP, Read KD, Cleypool CG, Ijzerman AP, Danhof M, de Boer AG. Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents. Eur J Pharm Sci 24: 59-66, 2005.
48. Shevock PN, Khan SR, Hackett RL. Urinary chemistry of the normal Sprague-Dawley rat. Urol Res 21: 309-312, 1993.
49. Sitaraman SV, Merlin D, Wang L, Wong M, Gewirtz AT, Si-Tahar M, Madara JL. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest 107: 861-869, 2001.
50. Truschel ST, Wang E, Ruiz WG, Leung SM, Rojas R, Lavelle J, Zeidel M, Stoffer D, Apodaca G. Stretch-regulated exocytosis/endocytosis in bladder umbrella cells. Mol Biol Cell 13: 830-846, 2002.
51. Vallon V, Osswald H. Adenosine receptors and the kidney. Hand Exp Pharmacol 193: 443-470, 2009.
52. Van Linden A, Eltzschig HK. Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26. Expert Opin Biol Ther 7: 1437-1447, 2007.
53. Wang E, Truschel S, Apodaca G. Analysis of hydrostatic pressureinduced changes in umbrella cell surface area. Methods 30: 207-217, 2003.
54. Wang EC, Lee JM, Ruiz WG, Balestreire EM, von Bodungen M, Barrick S, Cockayne DA, Birder LA, Apodaca G. ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115: 2412-2422, 2005.
55. Wei CJ, Li W, Chen JF. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim Biophys Acta 1808: 1358-1379, 2011.
56. Yoshimura N, de Groat WC. Neural control of the lower urinary tract. Int J Urol 4: 111-125, 1997.
57. Yu W, Zacharia LC, Jackson EK, Apodaca G. Adenosine receptor expression and function in bladder uroepithelium. Am J Physiol Cell Physiol 291: C254-C265, 2006.
58. Zhou Y, Murthy JN, Zeng D, Belardinelli L, Blackburn MR. Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. PLos One 5: e9224, 2010.